期刊文献+

人脐带间充质干细胞的分离、培养及其肝细胞生物学特性分析 被引量:5

Isolation,culture and hepatocyte biological characteristics detection of human umbilical cord stroma-derived mesenchymal stem cells
在线阅读 下载PDF
导出
摘要 目的:分离、培养人脐带基质来源的间充质干细胞(h UC-MSCs),观察其部分肝细胞生物学特性。方法:利用组织块贴壁培养法从脐带基质中分离培养h UC-MSCs,观察细胞形态,采用细胞免疫荧光法检测表面标记物CD44,通过RT-PCR法检测肝细胞标志基因ALB、CK18、G6P、GLUL、MET、TAT的表达情况,并进行PAS糖原染色。结果:从脐带基质分离出成纤维样细胞形态的h UC-MSCs,CD44表达阳性;RT-PCR结果表明培养的h UC-MSCs表达成熟肝细胞的标志基因ALB、CK18、G6P、GLUL和MET,而不表达TAT,PAS糖原染色呈阳性反应。结论:组织块贴壁培养法可有效获得稳定、均质性良好的h UC-MSCs,其具备部分肝细胞生物学特性。 Aim : To investigate the expressions of p53 and p21waf/cipl in blood of children with idiopathic short stature(ISS) and to elucidate the pathogenesis of ISS. Methods: Real-time PCR was used to measure the expressions of p53 mRNA and p21waf/cipl mRNA in peripheral blood from 30 children with ISS(ISS group) and 30 normal control( control group) ; ELISA was used to measure the levels of P53 and P21waf/cipl in serum of the children in the 2 groups. Results: The expression of p53 mRNA and the concentration of serum P53 had no statistical significance between the 2 groups( t = 1. 044 and 0. 701,P 〉 0.05). The expression of p21 waf/cipl mRNA in ISS group was significantly higher than those in the control group( t = 4. 066 ,P 〈 0. 001 ). Conclusion : p21waf/cipl may be responsible for the pathogenesis of ISS, which might not depends on p53 pathway.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2015年第2期187-191,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省基础与前沿技术研究项目资助092300410015,082300450560
关键词 脐带 间充质干细胞 肝细胞生物学特性 umbilical cord mesenchymal stem cell hepatocyte biological characteristic
  • 相关文献

参考文献15

  • 1Filippi C, Dhawan A. Current status of human hepatocyte transplantation and its potential for Wilson's disease[ J ]. Ann N Y Acad Sci,2014,1315:50.
  • 2Hughes RD, Mitry RR, Dhawan A. Current status of hepato- cyte transplantation [ J ]. Transplantation, 2012,93 ( 4 ) : 342.
  • 3Pareja E, Cortes M, G6mez-Lech6n M J, et al. Current status and future perspectives of hepatocyte transplantation [ J ]. Cir Esp,2014,92(2) :74.
  • 4Ballard TE,Orozco CC, Obach RS. Generation of major hu- man excreto and circulating drug metabolites using a hepatocyte relay method [ J ] Drug Metab Dispos, 2014,42 (5) :899.
  • 5Guguen-Guillouzo C, Guillouzo A. General review on in vitro hepatocyte models and their applications [ J ]. Methods Mol Bio1,2010,640 : 1.
  • 6Parekkadan B, van Poll D ,Suganuma K, et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic fail- ure[J]. PLoS One,2007,2(9) :e941.
  • 7Meier RP,Mahou R,Morel P,et al. Microencapsulated hu- man mesenchymal stem cells decrease liver fibrosis in mice [ J]. J Hepatol,2015,62(3) :634.
  • 8Volarevic V, Nurkovie J, Arsenijevie N,et al. Concise re- view:therapeutic potential of mesenehymal stem cells for the treatment of acute liver failure and eirrhosis[ J] Stem Cells,2014,32( 11 ) :2818.
  • 9van Poll D, Parekkadan B, Cho Ctt, et al. Mesenchymal stem cell-derived molecules directly modulate hepatoeellu- lar death and regeneration in vitro and in vivo[J]. Hepa- tology ,2008,47 ( 5 ) : 1634.
  • 10Lysy PA,Campard D,Smets F,et al. Persistence of a chi- merical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem eells[J]. Cell Prulif, 2008,41 ( 1 ) :36.

同被引文献43

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部